Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy.

Maglie, R; Ugolini, F; De Logu, F; Simi, S; Senatore, S; Montefusco, F; Nassini, R; Massi, D; Antiga, E

Maglie, R; Ugolini, F; De Logu, F; Simi, S; Senatore, S; Montefusco, F; Nassini, R; Massi, D; Antiga, E.

Afiliação

Maglie R; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Ugolini F; Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.
De Logu F; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
Simi S; Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.
Senatore S; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Montefusco F; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Nassini R; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
Massi D; Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.
Antiga E; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.

J Eur Acad Dermatol Venereol ; 35(8): e501-e503, 2021 Aug.

Article em En | MEDLINE | ID: mdl-33730368

Assuntos

Neoplasias Hematológicas; Leucemia Linfocítica Crônica de Células B; Dermatopatias; Anticorpos Monoclonais Humanizados; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Leucemia Linfocítica Crônica de Células B / Neoplasias Hematológicas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google